Production of α1,3-galactosyltransferase-knockout cloned pigs expressing human α1,2-fucosylosyltransferase

Biology of Reproduction

Volumn 69, Issue 2, 2003, Pages 437-445

  Ramsoondar, Jagdeece J ^a   Macháty, Zoltán ^a   Costa, Cristina ^a   Williams, Barry L ^a   Fodor, William L ^a,b   Bondioli, Kenneth R ^a  

^a ALEXION PHARMACEUTICALS   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Assisted reproductive technology; Embryo; Gamete biology; Gene regulation; Oocyte development

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; ANTIGEN; EPITOPE; FUCOSYLTRANSFERASE; GALACTOSYLTRANSFERASE; GLYCOSYLTRANSFERASE; NEOMYCIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CLONE; CONTROLLED STUDY; DNA MODIFICATION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE CONSTRUCT; GENE DISRUPTION; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENE TARGETING; GENETIC ENGINEERING; GENETIC SCREENING; GENOTYPE; HOMOZYGOTE; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; INTRON; KNOCKOUT GENE; MALE; NONHUMAN; ORGAN DONOR; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REPORTER GENE; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; SWINE; TECHNIQUE; TRANSGENE; TRANSLATION INITIATION; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOTTING, SOUTHERN; CELL NUCLEUS; CELLS, CULTURED; CLONING, ORGANISM; CODON; DNA PRIMERS; EXONS; FEMALE; FETUS; FIBROBLASTS; FLOW CYTOMETRY; FUCOSYLTRANSFERASES; GALACTOSYLTRANSFERASES; HUMANS; INTRONS; MALE; NEOMYCIN; OOCYTES; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TRANSFECTION;

ANIMALIA; SUS SCROFA;

EID: 0037623766     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.014647     Document Type: Article

References (28)

1. Auchincloss HJ, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16:433-470.
2. Stock UA, Vacanti JP. Tissue engineering: current state and prospects. Annu Rev Med 2001; 52:443-451.
3. Platt JL, Bach FH. Discordant xenografting: challenges and controversies. Curr Opin Immunol 1991; 3:735-739.
4. Good AH, Cooper DK, Malcolm AJ, Ippolito RM, Koren E, Neethling FA, Ye Y, Zuhdi N, Lamontagne LR. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24:559-562.
5. Xu Y, Lorf T, Sablinski T, Gianello P, Bailin M, Monroy R, Kozlowski T, Awwad M, Cooper DK, Sachs DH. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galalpha1-3Galbeta1-4betaGlc-X immunoaffinity column. Transplantation 1998; 65:172-179.
6. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995; 59:1325-1333.
7. Costa C, Brokaw JL, Wang Y, Fodor WL. Delayed rejection of porcine cartilage is averted by transgenic expression of α1,2-fucosyltransferase. FASEB J 2003; 17:109-111.
8. Blanken WM, Vanden Eijnden DH. Biosynthesis of terminal Gal alpha 1-3Gal beta 1-4GlcNAc-R oligosaccharide sequences on glycoconjugates. Purification and acceptor specificity of a UDP-Gal:N-acetyllactosaminide alpha 1-3-galactosyltransferase from calf thymus. J Biol Chem 1985; 260:12927-12934.
9. Lai L, Kolber-Simonds D, Park KW, Cheong HT, Greenstein JL, Im GS, Samuel M, Bonk A, Rieke A, Day BN, Murphy CN, Carter DB, Hawley RJ, Prather RS. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295:1089-1092.
10. Dai Y, Vaught TD, Boone J, Chen SH, Phelps CJ, Ball S, Monahan JA, Jobst PM, McCreath KJ, Lamborn AE, Cowell-Lucero JL, Wells KD, Colman A, Polejaeva IA, Ayares DL. Targeted disruption of the alpha 1,3-galactosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20:251-255.
11. Phelps CJ, Koike C, Vaught TD, Boone J, Wells KD, Chen S-H, Ball S, Specht SM, Polejaeva IA, Monahon JA, Jobst PM, Sharma SB, Lamborn AE, Garst AS, Moorc M, Demetris AJ, Rudert WA, Bottino R, Bertera S, Trucco M, Starzl TE, Dai Y, Ayares DL. Production of α1,3-galactosyltransferase-deficient pigs. Science 2003; 299:411-414.
12. Sandrin MS, Fodor WL, Mouhtouris E, Osman N, Cohney S, Rollins SA, Guilmette ER, Setter E, Squinto SP, McKenzie IF. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995; 1:1261-1267.
13. Costa C, Zhao L, Decesare S, Fodor WL. Comparative analysis of three genetic modifications designed to inhibit human serum-mediated cytolysis. Xenotransplantation 1999; 6:6-16.
14. Sharma A, Okabe J, Birch P, McClellan SB, Martin MJ, Platt JL, Logan JS. Reduction in the level of Gal (alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha (1,2) fucosyltransferase. Proc Natl Acad Sci U S A 1996; 93:7190-7195.
15. Cohney S, McKenzie IF, Patton K, Prenzoska J, Ostenreid K, Fodor WL, Sandrin MS. Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64:495-500.
16. Costa C, Zhao L, Burton WV, Bondioli KR, Williams BL, Hoagland TA, Ditullio PA, Ebert KM, Fodor WL. Expression of the human alpha 1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J 1999; 13:1762-1773.
17. Tanemura M, Miyagawa S, Koyota S, Koma M, Matsuda H, Tsuji S, Shirakura R, Taniguchi N. Reduction of the major swine xenoantigen, the alpha-galactosyl epitope by transfection of the alpha2,3-sialyltransferase gene. J Biol Chem 1998; 273:16421-16425.
18. Miyagawa S, Murakami H, Takahagi Y, Nakai R, Yamada M, Murase A, Koyota S, Koma M, Matsunami K, Fukuta D, Fujimura T, Shigehisa T, Okabe M, Nagashima H, Shirakura R, Taniguchi N. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001; 276:39310-39319.
19. Katayama A, Ogawa H, Kadomatsu K, Kurosawa N, Kobayashi T, Kaneda N, Uchimura K, Yokoyama I, Muramatsu T, Takagi H. Porcine alpha-1,3-galactosyltransferase: full length cDNA cloning, genomic organization, and analysis of splicing variants. Glycoconj J 1998; 15:583-589.
20. Strahan KM, Gu F, Preece AF, Gustavsson I, Andersson L, Gustafsson K. cDNA sequence and chromosome localization of pig alpha 1,3 galactosyltransferase. Immunogenetics 1995; 41:101-105.
21. Houdebine LM, Attal J. Internal ribosome entry sites (IRESs): reality and use. Transgenic Res 1999; 8:157-177.
22. te Riele H, Maandag ER, Berns A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc Natl Acad Sci U S A 1992; 89:5128-5132.
23. Bondioli K, Ramsoondar J, Williams B, Costa C, Fodor W. Cloned pigs generated from cultured skin fibroblasts derived from a H-transferase transgenic boar. Mol Reprod Dev 2001; 60:189-195.
24. Petters RM, Wells KD. Culture of pig embryos. J Reprod Fertil Suppl 1993; 48:61-73.
25. Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98:503-517.
26. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 1999; 234:187-208.
27. Sedivy JM, Dutriaux A. Gene targeting and somatic cell genetics - a rebirth or a coming of age? Trends Genet 1999; 15:88-90.
28. Brown JP, Wei W, Sedivy JM. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-834.